HK
Harold Phillip Koeffler

Elite Scholar

1,155
Works
65,298
Citations
122
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Harold Phillip Koeffler

Also known as: H KOEFFLER, H Koeffler, H P KOEFFLER, H P Koeffler, H Phillip Koeffler

1,155

Total Works

65,298

Citations

122

H-Index

648

i10-Index

Citation & Works Trend by Year
54 years active
Top Research Topics
Acute Myeloid Leukemia Research (296) Retinoids in leukemia and cellular processes (164) Cancer-related Molecular Pathways (140) Genomics and Chromatin Dynamics (103) Vitamin D Research Studies (96)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Retraction Notice to: “Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma” Gastroenterology 2018;154:2137–2151.e1 Gastroenterology 0
2026 Harnessing MDM2‐Mediated Targeted Degradation of Transcriptional and Epigenetic Machinery to Disrupt Oncogenic Addictions in Pediatric Sarcoma (Adv. Sci. 45/2026) Advanced Science 0
2026 Harnessing MDM2‐Mediated Targeted Degradation of Transcriptional and Epigenetic Machinery to Disrupt Oncogenic Addictions in Pediatric Sarcoma Advanced Science 1
2026 Correction: Shyamsunder et al. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. Int. J. Mol. Sci. 2022, 23, 1207 International Journal of Molecular Sciences 0
2026 qChIP-MS reveals the local chromatin composition by label-free quantitative proteomics Nature Communications 0
2026 Editor’s Note: Antitumor Activity of Suberoylanilide Hydroxamic Acid against Thyroid Cancer Cell Lines In vitro and In vivo Clinical Cancer Research 0
2026 XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation process Oncogene 1
2025 Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin Scientific Reports 0
2025 Supplementary Methods from Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis 0
2025 Supplementary Tables from Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis 0
2025 Supplementary Figures S1-S8 from Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis 0
2025 Retraction Note: Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets Journal of Hematology & Oncology 0
2025 Supplementary Data from PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells 0
2025 Supplementary file from Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy 0
2025 Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer Journal of Cancer Research and Clinical Oncology 0

Data source: OpenAlex API